Feb 5 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2018 Dec 31, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 47.22 49.64 63.00
(-4.9 pct) (+1.2 pct) (-2.4 pct)
Operating 3.06 4.59 4.30
(-33.3 pct) (+26.0 pct) (-11.0 pct)
Recurring 2.82 4.89 4.00
(-42.3 pct) (+39.6 pct) (-21.4 pct)
Net 2.90 3.96 3.60
(-26.7 pct) (+37.6 pct) (-13.4 pct)
EPS 57.96 yen 76.35 yen 72.37 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T